Diabetes Mellitus after Kidney Transplantation in the United States
Tóm tắt
Từ khóa
Tài liệu tham khảo
Cosio, 2001, Post-transplant diabetes mellitus: increasing incidence in renal allograft recipients transplanted in recent years, Kidney Int, 59, 732, 10.1046/j.1523-1755.2001.059002732.x
Friedman, 1985, Posttransplant diabetes in kidney transplant recipients, Am J Nephrol, 5, 196, 10.1159/000166932
Ascher, 1987, The impact of cyclosporine and combination immunosuppression on the incidence of posttransplant diabetes in renal allograft recipients, Transplantation, 44, 376, 10.1097/00007890-198709000-00010
Revanur, 2001, Influence of diabetes mellitus on patient and graft survival in recipients of kidney transplantation, Clin Transplant, 15, 89, 10.1034/j.1399-0012.2001.150202.x
Roth, 1989, Posttransplant hyperglycemia. Increased incidence in cyclosporine-treated renal allograft recipients, Transplantation, 47, 278, 10.1097/00007890-198902000-00016
Homel, 1998, Diabetes mellitus after renal transplantation: as deleterious as non- transplant-associated diabetes?, Transplantation, 65, 380, 10.1097/00007890-199802150-00014
Jawad, 2000, Posttransplant diabetes mellitus in live-related renal transplantation, Transplant Proc, 32, 1888, 10.1016/S0041-1345(00)01478-0
Davis, 1991, Posttransplant diabetes mellitus in cyclosporine-treated renal transplant recipients, Transplant Proc, 23, 1249
Hathaway, 1993, Development of an index to predict posttransplant diabetes mellitus, Clin Transplant, 7, 330, 10.1111/j.1399-0012.1993.tb00927.x
Stenstrom, 1997, Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age, Transplantation, 64, 979, 10.1097/00007890-199710150-00008
Von Kiparski, 1990, Post-transplant diabetes mellitus in renal allograft recipients: a matched-pair control study, Nephrol Dial Transplant, 5, 220, 10.1093/ndt/5.3.220
Rao, 1992, Post-renal transplant diabetes mellitus – a retrospective study, Nephrol Dial Transplant, 7, 1039
Vesco, 1996, Diabetes mellitus after renal transplantation: characteristics, outcome, and risk factors, Transplantation, 61, 1475, 10.1097/00007890-199605270-00011
Al-Uzri, 2001, Posttransplant diabetes mellitus in pediatric renal transplant recipients. a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS), Transplantation, 72, 1020, 10.1097/00007890-200109270-00007
Aikawa, 1988, Effect of cyclosporine on the endocrine and exocrine pancreas in kidney transplant recipients, Am J Kidney Dis, 12, 11, 10.1016/S0272-6386(88)80065-9
Tzakis, 1991, New onset of diabetes in FK 506 vs cyclosporine-treated kidney transplant recipients, Transplant Proc, 23, 3169
Isoniemi, 1991, Renal allograft immunosuppression V. Glucose intolerance occurring in different immunosuppressive treatments, Clin Transplantation, 5, 268, 10.1111/j.1399-0012.1991.tb00154.x
Ponticelli, 1996, Randomized study with cyclosporine in kidney transplantation: 10-year follow-up, J Am Soc Nephrol, 7, 792, 10.1681/ASN.V75792
Vincenti, 1996, One-year follow-up of an open-label trial of FK506 for primary kidney transplantation. A report of the U.S. Multicenter FK506 Kidney Transplant Group, Transplantation, 61, 1576, 10.1097/00007890-199606150-00005
Pirsch, 1997, A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group, Transplantation, 63, 977, 10.1097/00007890-199704150-00013
Besse, 1997, Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group, Transplantation, 64, 436, 10.1097/00007890-199708150-00012
Vivas, 1999, A prospective, randomized trial of tacrolimus/prednisone versus tacrolimus/prednisone/mycophenolate mofetil in renal transplant recipients, Transplantation, 67, 411, 10.1097/00007890-199902150-00012
Calne, 1999, Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group, Transplantation, 67, 1036, 10.1097/00007890-199904150-00017
Halloran, 2000, Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mycophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation, Transplantation, 69, 834
Miller, 2000, Safety and efficacy of tacrolimus in combination with mycophenolate mofetil (MMF) in cadaveric renal transplant recipients. FK506/MMF Dose-Ranging Kidney Transplant Study Group, Transplantation, 69, 875, 10.1097/00007890-200003150-00035
Hebert, 1999, Identifying persons with diabetes using Medicare claims data, Am J Med Qual, 14, 270, 10.1177/106286069901400607
Montori, 2002, Posttransplantation diabetes: a systematic review of the literature, Diabetes Care, 25, 592
Hammon, 2002, Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. Diabetes prevention program research group, New Engl J Med, 346, 393, 10.1056/NEJMoa012512
Allison, 1994, Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population, J Hepatol, 21, 1135, 10.1016/S0168-8278(05)80631-2
Perret, 1996, High prevalence of diabetes mellitus in patients with chronic hepatitis C. A case-control study, Gastroenterol Clin Biol, 20, 544
Knobler, 1998, Higher incidence of diabetes in liver transplant recipients with hepatitis C, J Clin Gastroenterol, 26, 30, 10.1097/00004836-199801000-00009
Qian, 1999, Association of diabetes mellitus and chronic hepatitis C virus infection, Hepatology, 29, 328, 10.1002/hep.510290235
Wanless, 2000, Hepatitis C-related cirrhosis: a predictor of diabetes after liver transplantation, Hepatology, 32, 87, 10.1053/jhep.2000.8270
Karavelioglu, 2000, Impact of HCV infection on development of posttransplantation diabetes mellitus in renal allograft recipients, Transplant Proc, 32, 561, 10.1016/S0041-1345(00)00890-3
Toffolo, 1999, Interferon-alpha improves glucose tolerance in diabetic and non- diabetic patients with HCV-induced liver disease, Exp Clin Endocrinol Diabetes, 107, 343